Azienda Ospedaliero-Universitaria Pisana, Dipartimento Diagnostica e Immagini, UO Radiodiagnostica 2, Via Paradisa 2, 56126, Pisa, Italy.
Azienda Ospedaliero-Universitaria Pisana, Dipartimento Cardiotoracovascolare, UO Pneumologia Universitaria, Via Paradisa 2, 56126, Pisa, Italy.
Eur J Radiol. 2020 Mar;124:108852. doi: 10.1016/j.ejrad.2020.108852. Epub 2020 Jan 28.
To investigate the role of a quantitative analysis software (CALIPER) in identifying HRCT thresholds predicting IPF patients' survival and lung function decline and its role in detecting changes of HRCT abnormalities related to treatment and their correlation with Forced Vital Capacity (FVC).
This retrospective study included 105 patients with a multidisciplinary diagnosis of IPF for whom one HRCT at baseline and concomitant FVC were available. HRCTs were evaluated with CALIPER and the correlation between FVC and radiological features were assessed. Radiological thresholds for survival prediction and functional decline were calculated for all patients. Fifty-nine patients with at least 2 serial HRCTs were classified into two groups based on treatment. For patients for whom a FVC within 3 months of the HRCT was available (n = 44), the correlation of radiological and clinical progression was evaluated.
The correlation between FVC and CALIPER-derived features at baseline was significant and strong. A baseline CALIPER-derived interstitial lung disease (ILD%) extent higher than 20 % and pulmonary vascular related structures (PVRS%) score greater than 5 % defined a worse prognosis. A significant progression of CALIPER-derived features in all patients was found with a faster increase in untreated patients. ILD% and PVRS% changes during follow-up demonstrated strong correlations with FVC changes.
CALIPER quantification of fibrosis and vascular involvement could distinguish disease progression in treated versus untreated patients and predict the survival. The changes in CALIPER-derived variables over time were significantly correlated to changes in FVC.
研究一种定量分析软件(CALIPER)在识别预测特发性肺纤维化(IPF)患者生存和肺功能下降的 HRCT 阈值方面的作用,及其在检测与治疗相关的 HRCT 异常变化及其与用力肺活量(FVC)的相关性方面的作用。
本回顾性研究纳入了 105 例经多学科诊断为 IPF 的患者,这些患者均在基线时有 1 次 HRCT 和同时期的 FVC。采用 CALIPER 对 HRCT 进行评估,并评估 FVC 与影像学特征之间的相关性。为所有患者计算生存预测和功能下降的 HRCT 阈值。对至少有 2 次 HRCT 的 59 例患者根据治疗进行分组。对于那些在 HRCT 后 3 个月内有 FVC 数据的患者(n = 44),评估了影像学和临床进展之间的相关性。
基线时 FVC 与 CALIPER 得出的特征之间的相关性具有显著意义且较强。基线时 CALIPER 得出的间质性肺病(ILD%)程度高于 20%和肺血管相关结构(PVRS%)评分大于 5%定义为预后较差。所有患者均发现 CALIPER 得出的特征有显著进展,未治疗患者的进展速度更快。在随访期间,ILD%和 PVRS%的变化与 FVC 的变化有很强的相关性。
CALIPER 对纤维化和血管受累的定量分析可以区分治疗与未治疗患者的疾病进展,并预测生存。CALIPER 得出的变量随时间的变化与 FVC 的变化有显著相关性。